AstraZeneca Forges Landmark $1.77 Billion Partnership with CSPC Pharmaceutical Group for Kidney Disease Therapeutics
AstraZeneca PLC (AZN), a global biopharmaceutical giant, has solidified a significant strategic partnership with CSPC Pharmaceutical Group Limited (CSPCY), one of China’s leading pharmaceutical companies, for the development and commercialization…
